The second NTHi vaccine in development is ChimV4, a chimera of protective epitopes from both rsPilA and OMP P5, which protects against development of NTHi-induced OM and resolves established NTHi biofilm in the chinchilla OM model (Novotny et al., 2013). The gene discussed is OMP; the disease is ocular melanoma.